ACRV

Acrivon Therapeutics, Inc.

Contracts

Total Value

Stock Metrics

8.0%

Short % Float

4.3d to cover · Moderate squeeze

50.3%

Inst % Float

10 holders · 2026-06-30

RA Capital Managem

Top Holder

28.6% of float

16.9M sh

Public Float

37/100

Dilution Score

Medium

16 mo

Cash Runway

Verified regulatory filings & proprietary analysis.

Dilution Risk

37/100

MEDIUM

Inst: 50.34% · Top: RA Capital Management, L.P.

Biotech Analytics

Biotech / Pharma

22.62

Squeeze risk: MODERATEBiotech Grade: F

Insider Buying0

Publications100

Dilution Risk37

Clinical Trials29

Short Interest30